The Clinical Impact of ABCB1 Polymorphisms on the Treatment of Psychiatric Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|26|2843-2851

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.26, 2011-09, pp. : 2843-2851

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential impact of ABCB1 (p-glycoprotein) polymorphisms on avermectin toxicity in humans

By Macdonald Neil   Gledhill Alex  

Archives of Toxicology, Vol. 81, Iss. 8, 2007-08 ,pp. : 553-563

Springer Publishing Company

Access to resources Recommend Favorite

Distribution of ABCB1 polymorphisms among Brazilians: impact of population admixture

By Estrela Rita CE   Ribeiro Fáábio S   Carvalho Renato S   Gregóório Sheila P   Dias-Neto Emmanuel   Struchiner Clááudio J   Suarez-Kurtz Guilherme  

Pharmacogenomics, Vol. 9, Iss. 3, 2008-03 ,pp. : 267-276

Future Medicine

Access to resources Recommend Favorite

Association of polymorphisms in NR1I2 and ABCB1 genes with epilepsy treatment responses

By Hung Chin-Chuan   Jen Tai John   Kao Pi-Ju   Lin Min-Shung   Liou Horng-Huei  

Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. : 1151-1158

Future Medicine

Access to resources Recommend Favorite

Genetic Polymorphisms of ATP-Binding Cassette Transporters ABCB1 and ABCC2 and their Impact on Drug Disposition

By  

Current Drug Targets, Vol. 12, Iss. 5, 2011-05 ,pp. : 631-646

Bentham Science Publishers

Access to resources Recommend Favorite

ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting

By  

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 33, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite